Last reviewed · How we verify
ALK tree AIT 0.5 DU — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
ALK tree AIT 0.5 DU (ALK tree AIT 0.5 DU) — ALK-Abelló A/S.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| ALK tree AIT 0.5 DU TARGET | ALK tree AIT 0.5 DU | ALK-Abelló A/S | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- ALK tree AIT 0.5 DU CI watch — RSS
- ALK tree AIT 0.5 DU CI watch — Atom
- ALK tree AIT 0.5 DU CI watch — JSON
- ALK tree AIT 0.5 DU alone — RSS
Cite this brief
Drug Landscape (2026). ALK tree AIT 0.5 DU — Competitive Intelligence Brief. https://druglandscape.com/ci/alk-tree-ait-0-5-du. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab